about the Study

Decreased sexual desire is a real medical condition that is also known as hypoactive sexual desire disorder, or HSDD.

The Reconnect Study is a clinical research study designed to evaluate the safety and effectiveness of a take “as needed” investigational medication for premenopausal women with decreased sexual desire.

You may feel that your decreased sexual desire is due to being busy, tired, or even a result of your age. It may be uncomfortable to discuss with others, but decreased sexual desire is a real medical condition that deserves attention.

The investigational medication is being tested to see if it may increase your desire. It is taken “as needed” shortly before a sexual encounter, could take effect within 45 minutes and could last for several hours.

about hypoactive sexual desire disorder

You may have hypoactive sexual desire disorder, or HSDD, if you experience:

  • A decrease in sexual desire
  • Distress over this lack of desire

HSDD affects up to 12% of women, as many as 8 million in the US. Participation in this study could lead to a new treatment for this condition and increased understanding of HSDD in premenopausal women.

See If You Qualify

some Personal Experiences

The Reconnect Study is personal, just like HSDD. In the past, many premenopausal women have felt uncomfortable discussing HSDD with their doctors, friends or loved ones. However, this common medical condition affects millions of premenopausal women similarly. Have you found yourself feeling like so many other premenopausal women?

"I am concerned about providing my partner with what is needed.”

“I want to feel more connected with my partner.”

“I find this really hard to talk about with friends and even my doctor.”

“When I talk to my doctor about this, they rarely have any advice.”

“It’s frustrating looking everywhere for an answer and not finding any.”

“I know it’s affecting the closeness of my relationship.”

FAQs: Clinical Research

A clinical research study is conducted to determine if potential new medications are safe and if they work. Clinical research studies are performed according to government regulations which help protect the safety and rights of study participants.

Yes, participation in any clinical research study is completely voluntary. If you decide to participate in a clinical research study, you are always free to withdraw at any time for any reason without any penalty or effect on your future medical care.

Informed consent is the process of learning the key facts and details about a clinical research study. This information will be provided to you before you decide to participate, as well as during your continued participation throughout the study. Once you have read the informed consent and understand the details including the risks and benefits, you can decide whether or not to sign the document. No study-related procedures will take place without a signed informed consent form.

An investigational study medication is a medication that has not yet been approved by the Food and Drug Administration for prescription by doctors. The medication that is being tested in this clinical research study is investigational.

Information about your personal health is private and confidential. With your permission, the information you provide about your medical history and health condition can be transferred to the study physician’s office of your choice.

If you pre-qualify for the study, a representative from the study physician’s office will contact you to further determine your interest and eligibility. Your personal information will not be disclosed to anyone outside of this clinical research study group without your consent unless disclosure is required by law or regulations of the Food and Drug Administration or similar agencies in other countries.

Scientific presentations of study results will not include information which could in any way identify you.

FAQs: The Reconnect Study

The Reconnect Study is evaluating an investigational “take as needed” medication for premenopausal women with HSDD.

You will be asked to review and sign an “Informed Consent Form” prior to study participation. If you qualify and sign the Informed Consent Form, you will be enrolled into the clinical research study.

Once enrolled, you will come to the physician study site for periodic visits for study exams to evaluate your general health and your HSDD symptoms.

Feel free to discuss your study-related medical care with the study physician or staff at any time during the course of the research study. It is important to take all study medication as prescribed and attend all scheduled visits. You will answer questions regarding how you feel during your participation, and whether the investigational medication has been taken at the appropriate times.

The Reconnect Study is being conducted by trained, qualified licensed physicians and medical specialists throughout the United States and Canada.

If you qualify for this research study, all study-related medical care and the investigational study medication will be provided to you at no cost. You do not need health insurance to participate.

Approximately 3000 premenopausal women at 160 physician research sites across the US and Canada will participate in this clinical research study. The investigational medication has already been studied in over 2300 patients across 31 clinical research studies.

You could experience side effects associated with the study medication. The study staff will discuss all of the possible risks and potential benefits in detail with you before you decide to participate in this research program.

A placebo does not contain any active ingredients and looks the same as the study medication. The use of a placebo is important in clinical research studies because it allows researchers to determine how well the active study medication may be working.

You have an equal chance of receiving either active study drug or placebo. Neither you nor the study doctor will be able to choose or know which study group you are in. However, the study doctor can find out if there is an emergency or if it is necessary to know for your health.

If you complete the research study, want to continue and are eligible, you may enter the extension phase of the study. During the extension phase all participants will receive the active study drug for one year.

After the research study is complete, all of the information is collected and analyzed to help determine the study medication’s safety and effectiveness.

If you complete the study, there is an option to participate in a year-long extension study, where all qualified participants will receive the investigational medication for one year.

No. However, it is a good idea to let your doctor know that you plan to participate in this research study. With your permission, your doctor can contact the study doctor for more information at any time.

The study doctor will not take the place of your usual doctor. You should continue to see your regular doctor for any non-study-related medical care.

You may be reimbursed for time, travel and other expenses.

Palatin Technologies is sponsoring this trial.

you may qualify if you...

  • Have experienced a decrease in your sexual desire over time
  • Feel distressed about this decreased sexual desire
  • Have been in a committed relationship for at least six months
  • Have not yet gone through menopause

Pre-Qualify Now